Health & Wellness

Atlantic Health System Cancer Care Offers Ovarian Cancer Screening Study

59a0db4105c65ecaf0d5_50a83ad445e5642aac3b_Dr._Dan_Tobias_2013.jpg..jpg..jpg
Dr. Dan Tobias Credits: courtesy photo
59a0db4105c65ecaf0d5_50a83ad445e5642aac3b_Dr._Dan_Tobias_2013.jpg..jpg..jpg

MORRISTOWN, NJ - When treated in its earliest stages, the five-year survival rate for ovarian cancer is more than 90 percent. Unfortunately, only 15 percent of cases are found at this early stage due to ovarian cancer's non-specific symptoms and lack of available early detection tests.

When discovered at a more advanced stage, the ovarian cancer survival rate can be as low as 18 percent.

The Women's Cancer Center at Carol G. Simon Cancer Center at Morristown and Overlook medical centers, is evaluating periodic blood tests that may be helpful in the early detection of ovarian cancer.

Sign Up for E-News

Ovarian Cancer Screening Trial recruitment days for new patients will take place from 9 a.m. to 2 p.m. at:

  •         Chilton Medical Center: July 17
  •         Overlook Medical Center: July 19
  •         Newton Medical Center: July 27
  •         Morristown Medical Center: August 4

Are you Eligible?

This study is available for women between 50 and 74 years old who:

  •         Are post-menopausal
  •         Are not and have not been in cancer treatment for the past 12 months (talk to study coordinator for exceptions)
  •         Have at least one ovary
  •         Have a health care provider


Study Procedures

  •         Telephone interview
  •         Blood test (annually or more often, if indicated)
  •         Medical history questionnaire and surveys
  •         Transvaginal ultrasounds (for some participants)
     

Study Benefits

  •         Receive possible ovarian cancer screening test at no cost
  •         Contribute valuable information to medical research
     

Why Join a Research Study?

Research studies, also known as clinical trials, are the most effective tools for evaluating new ways to prevent and treat cancer. Because of research studies, many people with cancer are living longer and enjoying a better quality of life.

By participating in cancer research, you advance medical science and help others who will battle cancer in the future.

To participate, or for more information, call 973-971-6491 or email Ovarian.Screening@atlantichealth.org.

Atlantic Health System and TAPinto Flemington are marketing partners, and this is published as an advertorial service to Atlantic Health and our readers.

TAP Into Another Town's News:

You May Also Be Interested In

Sign Up for E-News

Flemington/Raritan

Upcoming Events

Fri, February 23, 12:00 PM

Hunterdon Central High School Commons, Flemington

Hunterdon Rotary Soup Cook Off

Food & Drink

Tue, February 27, 8:30 AM

Raritan Learning Cooperative, Flemington

Raritan Learning Cooperative Open House

Education

AtlantiCast

AtlantiCast: Episode 12

On this week’s episode of AtlantiCast, decade of excellence makes headlines, as Atlantic Health’s place on Fortune Magazine’s 100 Best Companies to Work For List leads off the newest episode of AtlantiCast. Also on this week’s show, check out the newest “hybrid” operating room at Morristown Medical Center and find out how Atlantic Health is helping local ...

AtlantiCast Medical Minute: Atlantic Orthopedic Institute’s Scoliosis and Spinal Deformity Center

On this episode of the AtlantiCast Medical Minute, we’ll take you inside the Atlantic Orthopedic Institute’s Scoliosis and Spinal Deformity Center, with the center’s director, Jason Lowenstein, MD.

Video Link: https://www.youtube.com/watch?v=1M7euCp86-c

Thanks for 'Don't Miss Out' Campaign to Benefit Veterans

February 22, 2018

To the editor:

As a veteran, I want to thank our Hunterdon County Clerk Mary Melfi, our Freeholder board, and specifically, our Freeholder Director Matt Holt, for the "Don’t Miss Out" campaign. This campaign is spreading the word about the veterans' $3,000 tax exemption on the state income tax and is greatly appreciated because it is for all veterans, regardless of their ...